USPSTF Releases Final Recommendation on the Prevention of Falls in Community-Dwelling Older Adults; and Draft Recommendation for Public Comment and Evidence on Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions
- Final Recommendation Statement on Prevention of Falls in Community-Dwelling Older Adults
Yesterday, the Task Force posted its final recommendation statement on the Prevention of Falls in Community-Dwelling Older Adults. The final recommendation and the evidence it is based on is available here. A fact sheet that explains the final recommendation statement in plain language is also available on this Web page. The final recommendation was published in the online version of Annals of Internal Medicine.
- Draft Recommendation Statement on Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions
Today, the Task Force posted its draft recommendation statement on Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions. The recommendation is available for review and public comment from May 29 to June 26. To review the draft recommendation and submit comments, go here. To view the evidence that the draft recommendation statement is based on, go to http://www.uspreventiveservicestaskforce.org/uspstf/uspspmho.htm.
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the USPSTF Recommendations
Opportunity for Public Comment (USPSTF)
Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women
U.S. Preventive Services Task
Update in Progress section to see the latest documents available.
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on hormone replacement therapy.
Current RecommendationRelease Date: May 2005
- The USPSTF recommends against the routine use of
combined estrogen and progestin for the prevention of chronic conditions in
Grade: D Recommendation.
- The USPSTF recommends against the routine use of unopposed estrogen
for the prevention of chronic conditions in postmenopausal women who have had a
Grade: D Recommendation.
Supporting DocumentsRecommendation Statement (PDF File, 102 KB; PDF Help)
Summary of the Evidence, 2002 (PDF File, 138 KB; PDF Help)
Systematic Evidence Reviews, 2002
HRT and Breast Cancer (PDF Files Download)
HRT and Cardiovascular Disease (PDF Files Download)
HRT and Cognition (PDF Files Download)
HRT and Osteoporosis (PDF Files Download)
HRT and Venous Thromboembolism (PDF Files Download)
Update in ProgressIn an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of many of its documents for public comment, including draft Research Plans and draft Recommendation Statements. As a result, the final Recommendation Statement is not yet available.
Evidence ReportThe research team at the Evidence-based Practice Center independently gathers and reviews the available published evidence to address the questions posed by the USPSTF. The resulting draft Evidence Report is critiqued by national subject matter experts before being finalized.
|Evidence Report||Related Items|
|Evidence Report (PDF File, 150 KB; PDF Help)||Evidence Synthesis (PDF File, 1 MB; PDF Help)|
Recommendation StatementThe USPSTF reviews the Evidence Report, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more preliminary specific recommendations. The resulting draft Recommendation Statement is posted on this Web site for public comment before being finalized.
|Recommendation Statement||Related Items|
|Draft Recommendation Statement for Public
(May 29–June 26, 2012)
|Consumer Fact Sheet (PDF File, 442 KB; PDF Help)|
Current as of May 2012
Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women, Topic Page. May 2012. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspspmho.htm